These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 29425648)
1. Effect of rosmarinic acid on the arterial blood pressure in normotensive and hypertensive rats: Role of ACE. Ferreira LG; Evora PRB; Capellini VK; Albuquerque AA; Carvalho MTM; Gomes RADS; Parolini MT; Celotto AC Phytomedicine; 2018 Jan; 38():158-165. PubMed ID: 29425648 [TBL] [Abstract][Full Text] [Related]
2. Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects. Gainer JV; Morrow JD; Loveland A; King DJ; Brown NJ N Engl J Med; 1998 Oct; 339(18):1285-92. PubMed ID: 9791144 [TBL] [Abstract][Full Text] [Related]
3. Chronic treatment with quercetin does not inhibit angiotensin-converting enzyme in vivo or in vitro. Neto-Neves EM; Montenegro MF; Dias-Junior CA; Spiller F; Kanashiro A; Tanus-Santos JE Basic Clin Pharmacol Toxicol; 2010 Oct; 107(4):825-9. PubMed ID: 20406213 [TBL] [Abstract][Full Text] [Related]
4. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril. Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542 [TBL] [Abstract][Full Text] [Related]
5. Responses of blood pressure and angiotensin-converting enzyme activity to acute captopril administration in normotensive and hypertensive rats. Levens NR; Peach MJ; Vaughan ED; Weed WC; Carey RM Endocrinology; 1981 Feb; 108(2):536-44. PubMed ID: 6256155 [TBL] [Abstract][Full Text] [Related]
6. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries. Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724 [TBL] [Abstract][Full Text] [Related]
7. Captopril reverses the reduced vasodilator response to bradykinin in hypertensive pregnant rats. Resende AC; Pimentel AM; de Moura RS Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):756-61. PubMed ID: 15566389 [TBL] [Abstract][Full Text] [Related]
8. ACE activity during the hypotension produced by standardized aqueous extract of Cecropia glaziovii Sneth: a comparative study to captopril effects in rats. Ninahuaman MF; Souccar C; Lapa AJ; Lima-Landman MT Phytomedicine; 2007 May; 14(5):321-7. PubMed ID: 17433647 [TBL] [Abstract][Full Text] [Related]
9. Antihypertensive effects of isoquercitrin and extracts from Tropaeolum majus L.: evidence for the inhibition of angiotensin converting enzyme. Gasparotto Junior A; Gasparotto FM; Lourenço EL; Crestani S; Stefanello ME; Salvador MJ; da Silva-Santos JE; Marques MC; Kassuya CA J Ethnopharmacol; 2011 Mar; 134(2):363-72. PubMed ID: 21185932 [TBL] [Abstract][Full Text] [Related]
10. Captopril normalises systolic blood pressure in rats with hypertension induced by fetal exposure to maternal low protein diets. Langley-Evans SC; Jackson AA Comp Biochem Physiol A Physiol; 1995 Mar; 110(3):223-8. PubMed ID: 7712066 [TBL] [Abstract][Full Text] [Related]
11. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats. Bolterman RJ; Manriquez MC; Ortiz Ruiz MC; Juncos LA; Romero JC Hypertension; 2005 Oct; 46(4):943-7. PubMed ID: 16087785 [TBL] [Abstract][Full Text] [Related]
12. Dissociation of the effect of captopril on blood pressure and angiotensin converting enzyme in serum and lungs of spontaneously hypertensive rats. Forslund T; Tikkanen I; Grönhagen-Riska C; Fyhrquist F Acta Pharmacol Toxicol (Copenh); 1981 Nov; 49(5):416-21. PubMed ID: 6285670 [TBL] [Abstract][Full Text] [Related]
13. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca. Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904 [TBL] [Abstract][Full Text] [Related]
14. Pharmacology of idrapril: a new class of angiotensin converting enzyme inhibitors. Subissi A; Criscuoli M; Sardelli G; Guelfi M; Giachetti A J Cardiovasc Pharmacol; 1992 Jul; 20(1):139-46. PubMed ID: 1383623 [TBL] [Abstract][Full Text] [Related]
15. Bradykinin mediates the acute effect of an angiotensin-converting enzyme inhibitor on cerebral autoregulation in rats. Takada J; Ibayashi S; Nagao T; Ooboshi H; Kitazono T; Fujishima M Stroke; 2001 May; 32(5):1216-9. PubMed ID: 11340236 [TBL] [Abstract][Full Text] [Related]
16. Hypotensive and physiological effect of angiotensin converting enzyme inhibitory peptides derived from soy protein on spontaneously hypertensive rats. Wu J; Ding X J Agric Food Chem; 2001 Jan; 49(1):501-6. PubMed ID: 11170618 [TBL] [Abstract][Full Text] [Related]
17. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat. Sulpizio AC; Pullen MA; Edwards RM; Brooks DP J Pharmacol Exp Ther; 2004 Jun; 309(3):1141-7. PubMed ID: 14769834 [TBL] [Abstract][Full Text] [Related]
18. Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin. Montenegro MF; Pessa LR; Tanus-Santos JE Eur J Pharmacol; 2009 Apr; 607(1-3):173-7. PubMed ID: 19233159 [TBL] [Abstract][Full Text] [Related]